Item Type | Name |
Concept
|
Chronic Kidney Disease-Mineral and Bone Disorder
|
Concept
|
Disease Transmission, Infectious
|
Concept
|
Pulmonary Disease, Chronic Obstructive
|
Concept
|
Chronic Disease
|
Concept
|
Bone Diseases, Metabolic
|
Concept
|
Coronary Disease
|
Concept
|
Disease Progression
|
Concept
|
Kidney Diseases
|
Concept
|
Coronary Artery Disease
|
Concept
|
Acute Disease
|
Concept
|
Disease Management
|
Concept
|
Cardiovascular Diseases
|
Concept
|
Vascular Diseases
|
Concept
|
Carotid Artery Diseases
|
Concept
|
Hodgkin Disease
|
Concept
|
Heart Diseases
|
Concept
|
Metabolic Diseases
|
Academic Article
|
Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms.
|
Academic Article
|
Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials.
|
Academic Article
|
Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection.
|
Academic Article
|
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.
|
Academic Article
|
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.
|
Academic Article
|
Evidence for optimal hemoglobin targets in chronic kidney disease.
|
Academic Article
|
Haemoglobin targets: we were wrong, time to move on.
|
Academic Article
|
Timely referral alone may not be enough for patients with chronic kidney disease.
|
Academic Article
|
Impact of two different models on influenza and pneumococcal vaccination in hospitalized patients.
|
Academic Article
|
Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored?
|
Academic Article
|
An overlooked differential diagnosis of acute chest pain.
|
Academic Article
|
A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease.
|
Academic Article
|
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.
|
Academic Article
|
Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
|
Academic Article
|
Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.
|
Academic Article
|
Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis.
|
Academic Article
|
Anti-neutrophil cytoplasmic antibody associated crescentic IgA nephropathy in hematopoietic stem cell transplantation.
|
Academic Article
|
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.
|
Academic Article
|
Bariatric surgery and progression of chronic kidney disease.
|
Academic Article
|
HMG CoA reductase inhibitors (statins) for dialysis patients.
|
Academic Article
|
HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
|
Academic Article
|
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
|
Academic Article
|
Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder.
|
Academic Article
|
HMG CoA reductase inhibitors (statins) for dialysis patients.
|
Academic Article
|
Aldosterone antagonists for preventing the progression of chronic kidney disease.
|
Academic Article
|
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
|
Academic Article
|
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis.
|
Academic Article
|
Atrial natriuretic peptide for preventing and treating acute kidney injury.
|
Academic Article
|
Metabolic syndrome and mild to moderate chronic kidney disease among minorities.
|
Academic Article
|
Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients.
|
Academic Article
|
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.
|
Academic Article
|
Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
|
Academic Article
|
Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials.
|
Academic Article
|
Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.
|
Academic Article
|
Development and validation of an electronic health record-based chronic kidney disease registry.
|
Academic Article
|
Implications of the CKD-EPI GFR estimation equation in clinical practice.
|
Academic Article
|
Interventions for treating sexual dysfunction in patients with chronic kidney disease.
|
Academic Article
|
Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease.
|
Academic Article
|
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.
|
Academic Article
|
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.
|
Academic Article
|
Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD.
|
Academic Article
|
Metabolic syndrome and kidney disease: a systematic review and meta-analysis.
|
Academic Article
|
Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease.
|
Academic Article
|
Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006.
|
Academic Article
|
Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.
|
Academic Article
|
The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis.
|
Academic Article
|
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.
|
Academic Article
|
Obesity, anthropometric measures and chronic kidney disease complications.
|
Academic Article
|
Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study.
|
Academic Article
|
Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Electronic health records: a new tool to combat chronic kidney disease?
|
Academic Article
|
Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population.
|
Academic Article
|
HMG CoA reductase inhibitors (statins) for dialysis patients.
|
Academic Article
|
Albuminuria: when urine predicts kidney and cardiovascular disease.
|
Academic Article
|
Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the chronic renal insufficiency cohort study.
|
Academic Article
|
HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
|
Academic Article
|
Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.
|
Academic Article
|
Presence and outcomes of kidney disease in patients with pulmonary hypertension.
|
Academic Article
|
Darbepoetin for the anaemia of chronic kidney disease.
|
Academic Article
|
Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality.
|
Academic Article
|
Aldosterone antagonists for preventing the progression of chronic kidney disease.
|
Academic Article
|
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
|
Academic Article
|
Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease.
|
Academic Article
|
Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults.
|
Academic Article
|
Diabetic kidney disease: a report from an ADA Consensus Conference.
|
Academic Article
|
Diabetic kidney disease: a report from an ADA Consensus Conference.
|
Academic Article
|
Outcomes of infected cardiovascular implantable devices in dialysis patients.
|
Academic Article
|
Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study.
|
Academic Article
|
Patients as stakeholders in setting kidney disease research priorities.
|
Academic Article
|
Interventions for lowering plasma homocysteine levels in kidney transplant recipients.
|
Academic Article
|
Development of a chronic kidney disease patient navigator program.
|
Academic Article
|
Renal resistive index and mortality in chronic kidney disease.
|
Academic Article
|
Elevated pulmonary pressure: A novel risk marker in kidney disease?
|
Academic Article
|
Outcomes of transient ischemic attack in maintenance dialysis patients and those with chronic kidney disease.
|
Academic Article
|
Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
|
Academic Article
|
Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings.
|
Academic Article
|
A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease.
|
Academic Article
|
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.
|
Academic Article
|
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.
|
Academic Article
|
Safety analysis of primary bariatric surgery in patients on chronic dialysis.
|
Academic Article
|
Body mass index and causes of death in chronic kidney disease.
|
Academic Article
|
Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis.
|
Academic Article
|
Interventions for lowering plasma homocysteine levels in dialysis patients.
|
Academic Article
|
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
|
Academic Article
|
Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012.
|
Academic Article
|
A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial.
|
Academic Article
|
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for?death in chronic kidney disease.
|
Academic Article
|
Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease.
|
Academic Article
|
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.
|
Academic Article
|
Associations of dysnatremias with mortality in chronic kidney disease.
|
Academic Article
|
Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease.
|
Academic Article
|
Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk.
|
Academic Article
|
Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.
|
Academic Article
|
Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD.
|
Academic Article
|
Emerging therapeutic options for managing diabetic kidney disease.
|
Academic Article
|
Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease.
|
Academic Article
|
Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease.
|
Academic Article
|
Impact of Uric Acid Levels on Kidney Disease Progression.
|
Academic Article
|
Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis.
|
Academic Article
|
Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality.
|
Academic Article
|
High-density lipoprotein cholesterol and causes of death in chronic kidney disease.
|
Academic Article
|
Predicting timing of clinical outcomes in patients?with chronic kidney disease and severely decreased glomerular filtration rate.
|
Academic Article
|
Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease.
|
Academic Article
|
Association between intensity of statin therapy and mortality in persons with chronic kidney disease.
|
Academic Article
|
Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients.
|
Academic Article
|
Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study.
|
Academic Article
|
Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease.
|
Academic Article
|
Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.
|
Academic Article
|
Emerging therapeutic options for management of anaemia in with patients with chronic kidney disease.
|
Academic Article
|
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.
|
Academic Article
|
Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
|
Academic Article
|
What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry.
|
Academic Article
|
Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014).
|
Academic Article
|
Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.
|
Academic Article
|
Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease.
|
Grant
|
Visceral Adiposity and Physical Fitness in CKD
|
Concept
|
Global Burden of Disease
|
Concept
|
Non-alcoholic Fatty Liver Disease
|
Academic Article
|
Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.
|
Academic Article
|
Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.
|
Academic Article
|
[Hospitalization and Critical Illness in Chronic Kidney Disease].
|
Academic Article
|
Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease.
|
Academic Article
|
Editorial: Management of cardiovascular risk factors and other comorbidities in chronic kidney disease.
|
Academic Article
|
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
|
Academic Article
|
Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD.
|
Academic Article
|
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
|
Grant
|
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease
|
Academic Article
|
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
|
Academic Article
|
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline.
|
Academic Article
|
Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort?Study.
|
Academic Article
|
Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease.
|
Academic Article
|
Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5.
|
Academic Article
|
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
|
Academic Article
|
Nonesterified Fatty Acids and Kidney Function Decline in Older Adults: Findings From the Cardiovascular Health Study.
|
Academic Article
|
Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease.
|
Academic Article
|
Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes.
|
Academic Article
|
Treatment options for managing obesity in chronic kidney disease.
|
Academic Article
|
Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey.
|
Academic Article
|
Management of type 2 diabetes in chronic kidney disease.
|
Academic Article
|
Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs.
|
Academic Article
|
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.
|
Academic Article
|
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs).
|
Academic Article
|
A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?
|
Academic Article
|
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
|
Academic Article
|
Updated US Prevalence Estimates for Chronic Kidney Disease Stage and Complications Using the New Race-Free Equation to Estimate Glomerular Filtration Rate.
|
Academic Article
|
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1-3: a pilot study.
|
Academic Article
|
Revisiting diuretic choice in chronic kidney disease.
|
Academic Article
|
Progress in the management of patients with diabetes and chronic kidney disease.
|
Academic Article
|
Editorial: Advancements in the management of kidney disease and electrolyte derangements.
|
Academic Article
|
Steroidal or non-steroidal MRAs: should we still enable RAASi use through K binders?
|
Academic Article
|
Heart failure-type symptom scores in chronic kidney disease: The importance of body mass index.
|
Academic Article
|
Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol.
|
Academic Article
|
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
|
Academic Article
|
Heart Failure-Type Symptom Score Trajectories in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
|
Academic Article
|
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence.
|
Academic Article
|
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
|
Academic Article
|
Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in?the Chronic Renal Insufficiency Cohort (CRIC) Study.
|
Academic Article
|
Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
|
Academic Article
|
Echocardiographic parameters and cardiovascular disease in Japanese- and US-based CKD cohorts.
|
Academic Article
|
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs.
|
Academic Article
|
Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease.
|
Academic Article
|
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.
|
Academic Article
|
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes.
|
Academic Article
|
Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study.
|
Academic Article
|
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
|
Academic Article
|
Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression.
|